INTRODUCTION
A rise in the concentration of cytosolic free Ca# + ([Ca# + ] i ) is the major trigger for the contraction of smooth muscle [1] . Smooth muscle contraction is regulated by pharmacomechanical coupling mechanisms, whereby agonists induce contraction without depolarizing the membrane, and by electromechanical coupling mechanisms, which involve membrane depolarization [2] . Stimulation of vascular smooth muscle with various agonists leads to elevated [Ca# + ] i via Ca# + influx from the extracellular space through Ca# + -permeable non-specific cation channels [3] or voltage-dependent L-type Ca# + channels, and Ca# + release from the sarcoplasmic reticulum [4] . The elevation of [Ca# + ] i leads to calmodulin (CaM)-dependent activation of myosin light-chain kinase (MLCK) and hence phosphorylation of the 20-kDa light chains of myosin (LC #! ) II at Ser"* [5, 6] . This simple phosphorylation reaction triggers cycling of myosin cross-bridges along the actin filaments, which force development or shortening of the muscle. Relaxation generally occurs following a return of [Ca# + ] i to resting levels, resulting in dissociation of Ca# + from CaM, inactivation of MLCK and dephosphorylation of myosin catalysed by myosin light-chain phosphatase (MLCP), a myosin-associated type-1 protein serine\threonine phosphatase 20 , 20-kDa light chain of myosin ; MLCK, myosin light-chain kinase ; MLCP, myosin light-chain phosphatase ; NPY, neuropeptide Y ; PKC, protein kinase C ; ROK, Rho-associated kinase. 1 To whom correspondence should be addressed (e-mail mitsuom!my-pharm.ac.jp).
slightly reduced the phasic component. Phosphorylation levels of the 20-kDa light chain of myosin increased rapidly in response to 60 mM K + and subsequently declined to a steady-state level significantly greater than the resting level. Y-27632 abolished the sustained and reduced the phasic elevation of the phosphorylation of the 20-kDa light chain of myosin, without affecting the K + -induced elevation of cytosolic free Ca# + concentration. These results indicate that ROK activation plays an important role in the sustained phase of K + -induced contraction of rat caudal arterial smooth muscle, but has little involvement in the phasic component of K + -induced contraction. Furthermore, these results are consistent with inhibition of myosin light-chain phosphatase by ROK, which would account for the sustained elevation of myosin phosphorylation and tension in response to membrane depolarization.
Key words : HA-1077, ML-9, myosin phosphorylation, myosin light-chain kinase, Y-27632. [7] . However, [Ca# + ] i does not always parallel the extent of LC #! phosphorylation and contraction [8] [9] [10] [11] [12] [13] . During tonic force maintenance, for example, the relationship between force and LC #! -phosphorylation levels can be modified or even dissociated. Thus, secondary regulatory pathways are likely to be functionally important in the control of smooth muscle contractility. Additional important mechanisms of regulation that can modify the levels of LC #! phosphorylation and degree of contraction independent of [Ca# + ] i have been proposed, and are collectively referred to as Ca# + -sensitization mechanisms [2] . Ca# + -sensitizing agents include agonists that activate receptors coupled to heterotrimeric G-proteins, agents (GTP or the non-hydrolysable GTP analogue guanosine 5h-[γ-thio]triphosphate) that directly activate G-proteins [14] [15] [16] [17] , activators (phorbol esters) of conventional and novel protein kinase C (PKC) isoenzymes [14, 18] , and arachidonic acid [19] [20] [21] . Cellular signaling pathways involved in Ca# + sensitization converge on an increase in LC #! phosphorylation, and analyses of kinase and phosphatase activities have indicated that LC #! dephosphorylation is selectively reduced in this process, i.e. Ca# + sensitization is mediated by the inhibition of MLCP, rather than activation of MLCK [7, 22, 23] .
Several different mechanisms have been proposed to account for this inhibition of MLCP : (i) the small GTPase RhoA, a member of the Rho subfamily of the Ras superfamily of monomeric GTPases, activates Rho-associated kinase (ROK), which in turn phosphorylates the 130-kDa myosin-binding subunit of MLCP, inhibiting phosphatase activity [24] [25] [26] [27] [28] ; (ii) PKC [29] phosphorylates the protein kinase C-potentiated inhibitory protein for protein phosphatase-1 of 17-kDa (' CPI-17 ') [30] [31] [32] , which thereby becomes a potent inhibitor of MLCP; (iii) arachidonic acid inhibits MLCP activity either directly [19] , or via activation of an atypical PKC isoenzyme [21] or ROK [33] . Of these signal transduction pathways, the RhoA-ROK pathway appears to play a major role in agonist-induced Ca# + sensitization of smooth muscle contraction (reviewed in [34, 35] [36] . Therefore, K + -induced contraction may depend entirely on the influx of extracellular Ca# + and is not mediated by receptors. We reported previously [37, 38] α " -adrenoceptormediated contraction and phosphorylation of myosin in deendothelialized rat caudal arterial smooth muscle. During investigations into the role of the RhoA-ROK pathway in α " -adrenoceptor-mediated contraction in this tissue, we observed inhibition of K + -induced contraction by ROK inhibitors. However, little is known about the possible role of ROK in K + -induced contraction. The goal of this study, therefore, was to investigate the potential role of ROK in K + -induced contraction of rat caudal arterial smooth muscle. Specifically, we assessed the contributions of MLCK and ROK to K + -induced contraction of de-endothelialized rat caudal arterial smooth muscle using wellcharacterized inhibitors. We conclude that membrane depolarization with the influx of extracellular Ca# + activates ROK, in addition to MLCK, and ROK activation is required for the sustained, but not the phasic, contractile response to depolarization. HA-1077 was from ICN Biomedicals (Aurora, OH, U.S.A.). Dithiothreitol (DTT) was from Wako Pure Chemical Industries (Osaka, Japan). Hepes and fura 2 acetoxymethyl ester (fura 2\AM) were from Dojindo Laboratories (Kumamoto, Japan). All other chemicals were of reagent grade. Stock solutions were prepared in water for prazosin, propranolol, Y-27632 and HA-1077, and in DMSO for ML-9.
MATERIALS AND METHODS

Materials
Prazosin [1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furan- ylcarbonyl)-piperazine], -propranolol [1-(isopropylamino)-3-
Preparation of muscle strips
Male Sprague-Dawley rats (300-400 g) were killed by a blow on the neck and exsanguination, as approved by the Institutional Ethics Committee for Animal Research (Meiji Pharmaceutical University). Caudal arterial smooth muscle strips were prepared by the method of Mita and Walsh [37] . The endothelial layer and adventitial tissue were removed mechanically. Helical strips [0.5 mmi(6-7) mm] were cut and stored in Hepes\Tyrode (H-T) solution (137 mM NaCl, 2.7 mM KCl, 1.8 mM CaCl # , 1 mM MgCl # , 5.6 mM glucose and 10 mM Hepes, pH 7.4).
Force measurements
De-endothelialized muscle strips were mounted horizontally between two hooks and immersed in a pool of solution (750 µl), which was rounded by surface tension on a rotation plate of 4-cm diameter. One hook was connected to a force displacement transducer (TB-612T; Nihon Kohden, Tokyo, Japan) that was mounted on a micromanipulator, and the other to a second micromanipulator. Solution changes were effected rapidly by rotation of the plate. A resting tension of 75 mg was determined experimentally to give a maximal contractile response to 40 mM KCl and was used for all experiments. Once mounted, deendothelialized muscle strips were held at this resting tension in H-T solution at 24 mC for 45 min, and then transferred to H-T solution in the presence of 1 µM prazosin and 0.1 µM propranolol for 10 min, before transfer to 60 mM K + solution in the presence of 1 µM prazosin and 0.1 µM propranolol. After stable 60 mM K + -induced contractions were achieved in the presence of 1 µM prazosin and 0.1 µM propranolol, the strips were transferred to H-T solution in the presence of 1 µM prazosin and 0.1 µM propranolol for 45 min before transfer to the test solutions (containing 1 µM prazosin and 0.1 µM propranolol), as indicated below. All buffers were at 24 mC and those used for intact strips were pre-oxygenated with 100 % O # . K + solution (60 mM) was prepared by replacing the NaCl in H-T solution with equimolar KCl. K + (60 mM) induced a sub-maximal contraction (approx. 78.1 % of the maximal contraction) of rat caudal arterial smooth muscle.
Measurement of changes in intracellular Ca
2 + concentration Muscle strips were incubated with H-T solution containing 16 µM fura 2\AM for 4 h in the dark at 24 mC. Fura 2-loaded muscle strips were washed with H-T solution containing 1 µM prazosin and 0.1 µM propranolol for 30 min. The fluorescence of the mounted muscle strips was recorded at an emission wavelength of 500 nm, with excitation at 340 nm, and 380 nm, using a CAF-100 spectrofluorimeter (Jasco, Tokyo, Japan). The fluorescence ratio (F $%! \F $)! ) was monitored before (resting state) and during stimulation with 60 mM K + for 20 min in the absence and presence of 3 µM Y-27632.
Quantification of LC 20 phosphorylation
Quantification of LC #! phosphorylation was achieved by the method of Mita and Walsh [37] . Tissue samples were frozen at selected times, following 60 mM K + stimulation by immersion in 10 % trichloroacetic acid\10 mM DTT in solid CO # \acetone for 10 min. Frozen muscle strips were then washed with 10 mM DTT in acetone at 24 mC. The tissues were freeze-dried overnight and stored at k80 mC until LC #! extraction was carried out. Proteins were extracted from tissue strips in 30 µl of extraction buffer (6 M deionized urea, 20.1 mM Tris, 22.2 mM glycine, 10 mM DTT, 10 mM EGTA, 1 mM EDTA, 1 mM PMSF, 0.6 M KI and 0.15 mM Bromophenol Blue) by constant rotation in a microcentrifuge tube for 90 min at 24 mC. After filtration and centrifugation, phosphorylated and unphosphorylated LC #! were separated by urea\glycerol gel electrophoresis, and were trans-A B
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Figure 1 Effect of ML-9 on K + -induced contraction of rat caudal arterial smooth muscle
(A) Effect of ML-9 on K + -induced sustained contraction of rat caudal arterial smooth muscle. ML-9 was added at the indicated concentrations to muscle strips that exhibited steady 60 mM K + -induced tonic contraction, and the time-course of relaxation was followed. Force is expressed as a percentage of the force of the tonic contraction developed in response to K + before the addition of ML-9. The inset shows that treatment with vehicle (DMSO) alone [up to 1 % (the maximal concentration used)] had no effect on K + -induced contraction. Results are expressed as the meanspS.E.M. (n l 8). (B) A typical trace showing the effect of pre-treatment with ML-9 on K + -induced contraction of rat caudal arterial smooth muscle. After stable 60 mM K + -induced contractions were achieved, strips were relaxed and incubated for 20 min with 30 µM ML-9 prior to K + depolarization. The trace is representative of four experiments. (C) Effect of pre-treatment with ML-9 on K + -induced contraction of rat caudal arterial smooth muscle. After stable 60 mM K + -induced contractions were achieved, strips were relaxed and incubated for 20 min with ML-9 prior to K + depolarization. Upper panels show the time-courses of K + -induced contraction in the absence of ML-9 (#) or presence of the indicated concentrations of ML-9 ($). Lower panels show the effects of ML-9 on the phasic and tonic components of K + -induced contraction. Force development is expressed as a percentage of the maximal force of the phasic contraction developed in response to 60 mM K + without ML-9. The force of the tonic component was measured 30 min after K + addition. blotted on to 0.2-µm nitrocellulose membrane (BioRad, Mississauga, Ontario, Canada) in 10 mM sodium cyclohexylaminopropanesulphonic acid, pH 11, in a Mini Transblot Cell (BioRad) at 27 V and 5 mC for 16 h. LC #! was detected using a polyclonal antibody raised in rabbits against purified chicken gizzard LC #! [37, 38] . The antibody was purified from antiserum using HiTrap Protein A (Pharmacia, Baie d 'Urfe, Que! bec, Canada) and was used at a dilution of 1 :1000 with the BM Chemiluminescence Western Blotting Kit (Roche, Mannheim, Germany), according to the manufacturer's instructions. Phosphorylated and unphosphorylated LC #! bands were quantified by densitometric scanning using a Pharmacia Image Master Desktop Scanning System. LC #! phosphorylation levels were calculated by dividing the chemiluminescence signal (absorbanceiarea of the band) of the phosphorylated LC #! peak by the total chemiluminescence signal of the phosphorylated and unphosphorylated LC #! peaks. We observed no diphosphorylated LC #! in any experiment.
Statistical analysis
All statistical analyses were performed using StatView-J5.0 (SAS Institute, Cary, NC, U.S.A.). Student's paired or unpaired t tests were performed and P 0.05 was considered significant. Results are expressed as the meanspS.E.M. Values of n indicate the numbers of strips.
RESULTS
Characterization of K + -induced contraction of rat caudal arterial smooth muscle
All experiments were carried out in the presence of 1 µM prazosin and 0.1 µM propranolol in order to block the α " -and β-adrenergic effects of noradrenaline, which is released from nerve terminals by depolarization [39] . The addition of 60 mM K + to deendothelialized helical strips of rat caudal arterial smooth muscle induced a contraction that peaked rapidly and then declined to a steady level corresponding to approx. 30 % of the peak contraction ( Figures 1B and 1C) . The forces of the phasic and tonic components of contraction evoked by 60 mM K + were 247.8p13.4 mg and 76.9p8.6 mg (n l 4) respectively.
Tetrodotoxin (0.1 µM) or the P # purinoceptor antagonist suramine (10 µM) did not affect 60 mM K + -induced contraction, indicating that release of ATP or neuropeptide Y, which are costored and co-released with noradrenaline from sympathetic nerve terminals [40] [41] [42] [43] , is not involved in K + -induced contraction (results not shown). Furthermore, the cyclo-oxygenase inhibitor indomethacin (3 µM) had no effect on K + -induced contraction, indicating that prostaglandins also do not play a role in the contractile response to membrane depolarization (results not shown).
Both the phasic and tonic components of 60 mM K + -induced contraction were completely abolished by the Ca# + -channel blocker nicardipine or brief treatment with Ca# + -free solution containing 2 mM EGTA for 1 min to remove extracellular Ca# + (results not shown). The K + -induced contraction was fully restored following replacement of extracellular Ca# + . 
Effects of ML-9 on K + -induced contraction
An MLCK inhibitor, ML-9, potently inhibited 60 mM K + -induced sustained contraction, causing a concentration-dependent relaxation to below the basal level of force with an IC &! value of 2.39p0.32 µM ( Figure 1A) . Treatment with vehicle (DMSO) alone had no effect on K + -induced contraction ( Figure  1A, inset) . Pre-treatment of muscle strips with ML-9 inhibited both the phasic and tonic components of K + -induced contraction in a concentration-dependent manner (Figures 1B and 1C) .
Effects of Y-27632 and HA-1077 on K + -induced contraction
The ROK inhibitors, Y-27632 and HA-1077, potently inhibited K + -induced sustained contraction, causing a concentrationdependent relaxation to the basal force with IC &! values of 0.41p0.02 µM and 0.49p0.06 µM respectively (Figure 2) . Force was well maintained in the vehicle (water) alone over the same number of solution changes for the same duration (results not shown). Pre-treatment of muscle strips with Y-27632 (Figure 3) or HA-1077 (Figure 4 ) potently inhibited the tonic component of K + -induced contraction with a small, but significant, decrease in the phasic component. Furthermore, pre-treatment with the ROK inhibitors increased the rate of relaxation after the peak response (Figures 3 and 4) . 
Effect of Y-27632 on [Ca
Effect of Y-27632 on LC 20 phosphorylation
Under control conditions, LC #! phosphorylation levels paralleled force, increasing rapidly in response to 60 mM K + from a resting level of 0.12p0.04 mol of P i \mol of LC #! to a peak of 0.54p0.03 mol of P i \mol of LC #! at 15 s after 60 mM K + addition ( Figure 6 ). LC #! phosphorylation then declined to a steady level of 0.35p0.08 mol of P i \mol of LC #! at 15 min after K + addition. In the presence of 3 µM Y-27632, LC #! phosphorylation levels increased rapidly in response to K + from a resting level of 0.18p0.03 mol of P i \mol of LC #! to a peak of 0.34p0.06 mol of P i \mol of LC #! at 15 s after 60 mM K + addition and then declined rapidly to resting levels ( Figure 6 ). Thus, Y-27632 reduced the transient increase in LC #! phosphorylation, but completely abolished the sustained elevation of LC #! phosphorylation (0.14p0.05 mol of P i \mol of LC #! at 15 min after 60 mM K + addition, which is indistinguishable from the resting value).
DISCUSSION
Electromechanical coupling describes the signaling pathways whereby depolarization of the sarcolemma leads to muscle Rho-associated kinase and K + -induced smooth muscle contraction contraction. In the context of smooth muscle contraction, it is well established that membrane depolarization opens voltagegated Ca# + channels allowing Ca# + entry to the cytosol [4] . The increase in [Ca# + ] i results in binding of Ca# + to CaM, which activates MLCK. The active kinase then catalyses phosphorylation of myosin, which triggers cross-bridge cycling [2] . During the course of studies of pharmacomechanical coupling mechanisms [44] , which trigger contraction without a change in membrane potential, we obtained evidence from the control experiments that depolarization of the smooth muscle sarcolemma by K + results in activation of ROK, which could play a role in the contractile response. This prompted us to conduct a detailed analysis of the activation of this kinase by membrane depolarization and its potential involvement in this contractile response. Therefore, in the present study, we examined the effects of two well-characterized selective ROK inhibitors on the contractile properties of endothelium-free smooth muscle helical strips of the rat caudal artery. In order to eliminate effects of noradrenaline released from nerve terminals, prazosin and propranolol were used to block the α " -and β-adrenergic effects of this neurotransmitter. It was found unnecessary to antagonize other neurotransmitters, such as ATP and neuropeptide Y or prostaglandins.
The contractile response to K + -induced membrane depolarization was found to be absolutely dependent on the influx of Ca# + through voltage-gated Ca# + channels, since it could be blocked by a Ca# + -channel blocker or by removal of extracellular Ca# + . This contrasts with α " -adrenoceptor-induced contraction of the rat caudal artery, in which the phasic component involves the release of Ca# + from the sarcoplasmic reticulum, whereas the tonic component involves influx of Ca# + from the extracellular milieu [37] .
K + -induced contraction of rat caudal arterial smooth muscle strips was inhibited by ML-9, a highly selective inhibitor of MLCK with a K i value of 3.8 µM [45, 46] , similar to the IC &! value for inhibition of K + -induced contraction obtained in the present study (2.39p0.32 µM). It is noticeable that ML-9-induced relaxation to levels of force well below resting levels ( Figure 1A) , suggesting that resting tone is due to the low basal level of LC #! phosphorylation (0.12 mol of P i \mol of LC #! ; Figure 6 ) and that MLCK is responsible for this basal phosphorylation. Pre-treatment of arterial strips with ML-9 inhibited both the phasic and tonic components of K + -induced contraction in a concentration-dependent manner (Figures 1B and 1C) .
Ca# + sensitization of smooth muscle contraction involves the small GTPase RhoA. Agonists activate RhoA via receptors that are coupled to the G "#/"$ family of heterotrimeric G-proteins [47] , and the activated RhoA interacts with and activates ROK [34] . Activated ROK subsequently phosphorylates the 130-kDa myosin-binding subunit of MLCP [27] , inhibiting the activity of MLCP [28, 48] . Y-27632 [49] and HA-1077 [50] are selective ROK inhibitors, and Ca# + sensitization induced by receptor stimulation or the activation of G-proteins is inhibited by these compounds. In the present study, the K + -induced sustained contraction of smooth muscle strips was inhibited by Y-27632 and HA-1077 in a concentration-dependent manner with IC &! values of 0.41p0.02 µM and 0.49p0.06 µM respectively ( Figure  2 ). These IC &! values are similar to previously reported values for agonist-induced contractions and to the K i values reported using purified ROK (0.14 µM for Y-27632 and 0.40 µM for HA-1077) [49, 50] . We observed that pre-treatment of arterial strips with Y-27632 or HA-1077 abolished the tonic component of K + -induced contraction, with a relatively minor effect on the phasic component (Figures 3 and 4) . On the other hand, the ROK inhibitors Figure 1C) , enhance the rate of relaxation following the peak of the phasic component of K + -induced contraction, which is consistent with an increase in MLCP activity and faster LC #! dephosphorylation. We conclude, therefore, that the tonic component of K + -induced contraction involves activation of ROK with resultant inhibition of MLCP. Similar results were obtained by receptor stimulation of guinea-pig ileum [28] . Pre-treatment with HA-1077 abolished the tonic component of carbachol-induced contraction and the sustained elevation of LC #! phosphorylation, but had no effect on the transient or sustained increase in [Ca# + ] i . These results indicate that physiological elevations of [Ca# + ] i and the consequent MLCK activation are not sufficient to cause a full-force response, unless GTPase-dependent pathways leading to MLCP inhibition are simultaneously activated. It therefore seems likely that maintained contraction in response to K + , as well as agonists, depends on both MLCK and ROK activities. In contrast with our present observations with rat caudal artery, Uehata et al. [49] reported that Y-27632 caused a small concentration-dependent inhibition of contraction induced by high [K + ] in rabbit aortic strips. These two vascular smooth muscles exhibit major differences in their contractile responses to K + : in the rat caudal artery, the initial phasic force transient is followed by a decline in tension (Figures 1, 3 and 4) , whereas in the rabbit aorta there is a continuous increase in tension during prolonged depolarization [51] . This difference is likely due to regional and species differences in the action potentials between these two smooth muscle cell types. It is generally assumed that vascular smooth muscle cells in capacitative vessels, similar to the aorta, are electrically quiescent (reviewed in [52] ). It seems, therefore, that the smooth muscle of caudal artery may exhibit qualitatively different electrical properties from those of the aorta, and there may be some divergence between the generation of electrical events and contractile signal transduction. Smooth muscle can be classified into two major subtypes : phasic and tonic [53] . Smooth muscles respond to K + depolarization with a relatively rapid contraction that, in phasic smooth muscles, declines within minutes to an intermediate level, whereas, in tonic smooth muscles, it is followed by sustained increases in force for up to 30 min [54] . It has been suggested that the Ca# + sensitivity of the contractile elements might differ between phasic and tonic Figure 7 Proposed signal transduction pathways involved in K + -induced contraction of rat caudal arterial smooth muscle smooth muscles [55] . In addition, MLCP and MLCK activities vary among smooth muscles : MLCP and MLCK activities are 2.0-and 1.9-fold lower respectively in tonic compared with phasic smooth muscles [56] . Smooth muscle-specific differences between the inhibitory effects of Y-27632 on K + -induced contractions of different smooth muscles may, therefore, be due to differences in MLCP activity in different smooth muscles.
Phosphorylation levels of LC #! increased rapidly in response to 60 mM K + and declined to a steady-state level that was significantly higher than the resting level ( Figure 6 ). This phosphorylation of LC #! closely matched the time-course of contraction. Y-27632 (3 µM) had a modest inhibitory effect on the transient increase in LC #! phosphorylation ( Figure 6 ). This effect was maximal since, in the presence of a higher concentration of Y-27632 (10 µM), LC #! phosphorylation levels also increased rapidly in response to K + to the same level (0.34p0.03 mol of P i \mol of LC #! 15 s after 60 mM K + addition) (results not shown). On the other hand, Y-27632 (3 µM) abolished the sustained elevation of LC #! phosphorylation ( Figure 6 ). The time courses of LC #! phosphorylation, therefore, correlate well with the force responses to 60 mM K + in the absence and presence of Y-27632. We conclude that the tonic phase of K + -induced contraction is mediated via inhibition of MLCP activity by ROK activation, and requires MLCK activity. Swa$ rd et al. [28] reported a similar finding for carbachol-induced contraction of guinea-pig ileum : pre-treatment of intact ileal strips with HA-1077 abolished the tonic component of carbachol-induced contraction and the sustained elevation of LC #! phosphorylation, but had little effect on the phasic contraction or the transient increase in LC #! phosphorylation induced by carbachol, suggesting that the ROKmediated increase in LC #! phosphorylation is due to MLCP inhibition, not MLCK activation.
In fura 2-loaded rat caudal arterial strips, the time course of the change in [Ca# + ] i stimulated by K + closely matched the time courses of contraction and LC #! phosphorylation (Figures 3-6 ). Moreover, Y-27632 had no significant effect on K + -induced changes in [Ca# + ] i ( Figure 5 ). HA-1077 also had no effect on the K + -induced Ca# + transient (results not shown). ROK inhibitors, therefore, caused complete reduction of sustained contraction without associated changes in [Ca# + ] i . It was reported that in guinea-pig trachealis Y-27632 inhibited methacholine-induced [Ca# + ] i elevation in a concentration-dependent manner with an IC &! value of 524.1p31.0 µM [57] . However, at the concentrations of Y-27632 used in our experiments (1-10 µM), methacholine-induced contraction was inhibited with little change in [Ca# + ] i . We suggest, therefore, that during the phasic component of K + -induced contraction, [Ca# + ] i is high enough to activate MLCK to a level that is much greater than that of MLCP. However, the lower [Ca# + ] i during the sustained contraction may not be high enough to activate MLCK to a level sufficient to overcome the phosphatase. In this case, inhibition of MLCP by ROK is required for the activity ratio of MLCK to MLCP to shift far enough in the direction of the kinase to maintain LC #! phosphorylation elevated. These results suggest that RhoA\ROK activation plays an important role in the tonic component of K + -induced contraction and LC #! phosphorylation in rat caudal arterial smooth muscle, but has no significant role in the phasic component.
In conclusion, our results indicate that vascular smooth muscle contraction elicited by membrane depolarization comprises two phases, both of which are dependent on influx of extracellular Ca# + (Figure 7 ) : (i) a rapid phasic component that involves phosphorylation of myosin by Ca# + \CaM-dependent MLCK and (ii) a sustained tonic component that involves these mechanisms, as well as activation of ROK and Ca# + sensitization.
